ALEX LIU
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GILBERT, AZ NPI 1306335047
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology AZ AVEO Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,885.37
- Category: General Payments
- Program years: PY2021–2024
- Record count: 43
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $764.22 across 29 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $664.27 | 28 |
| Education | $99.95 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| AVEO Pharmaceuticals, Inc. | $99.95 | 1 |
| Daiichi Sankyo Inc. | $81.11 | 3 |
| Gilead Sciences, Inc. | $59.54 | 2 |
| Merck Sharp & Dohme Corporation | $57.50 | 3 |
| Janssen Biotech, Inc. | $42.64 | 2 |
| EISAI INC. | $41.48 | 2 |
| SOBI, INC | $41.44 | 2 |
| Acerta Pharma LLC | $37.26 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.37 | 2 |
| TerSera Therapeutics LLC | $34.20 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.36 | 1 |
| Genmab U.S., Inc. | $32.74 | 1 |
| GlaxoSmithKline, LLC. | $29.44 | 1 |
| Celgene Corporation | $29.08 | 1 |
| PFIZER INC. | $28.37 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.87 | 1 |
| Rigel Pharmaceuticals, Inc. | $24.83 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.85 | 1 |
| Karyopharm Therapeutics Inc. | $13.19 | 1 |
By program year
Records — PY2024 (29)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.